This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Athens Regional Medical Center Upgrades To Omnicell G4 Platform For Supply And Medication Management

Stocks in this article: OMCL

MOUNTAIN VIEW, Calif., Nov. 3, 2011 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that Athens Regional Medical Center has upgraded its Omnicell supply and medication management solutions with the new fourth generation Omnicell® G4 platform. After nearly a decade as an Omnicell pharmacy and supply automation customer, the medical center's upgrade demonstrates its commitment to improving patient care and clinician efficiency.

Committed to advancing medication and supply automation management, Athens Regional began its Omnicell G4 platform upgrade process in mid-2011 with the G4 OptiFlex™ MS for surgical supply management and OptiFlex CL for interventional radiology needs. The medical center's next G4 upgrades are scheduled to go live in January 2012 with enhanced medication management technology, including the OmniRx® G4 Automated Medication Dispensing Cabinets (ADCs) to efficiently manage, store, and dispense medications throughout the medical center. At the same time, Athens Regional intends go live with Omnicell's Controlled Substance Management System (CSM) to provide perpetual inventory management and closed-loop tracking for controlled substances.

"Omnicell has been an innovative partner for years, and with the G4 platform we will remain at the forefront of automation technology with secure and efficient medication and supply delivery," said Don Tyson, director of pharmacy services at Athens Regional Medical Center. "We chose to upgrade to the new G4 platform to improve nursing and clinician workflow and expand the patient safety initiatives that are currently in place at Athens."

During the January 2012 G4 upgrade go-live, Athens Regional Medical Center plans to customize its OmniRx G4 Automated Medication Dispensing Cabinets (ADCs) with key software and hardware options, including:

  • The new Touch & Go™ Biometric System, which employs state-of-the-art biometrics hardware and software fingerprint authentication to ensure secure, convenient medication access.
  • The integrated Medication Label Printer, which allows nurses to print individually-barcoded patient-specific labels, will better enable Athens to deploy bedside barcoding in the future.
  • Anywhere RN™ Remote Medication Management, which allows nurses to remotely access and select medication orders for the Omnicell dispensing cabinets to streamline workflow and eliminate waiting lines at the ADCs.

The completed installation of G4 OptiFlex Supply Solutions enhances the medical inventory management process and streamlines workflow allowing for better focus on patient care. OptiFlex is expected to help reduce excessive inventory, and associated costs, in the surgery and interventional radiology departments. The upgrade follows Athens Regional's recent installation of the OptiFlex Bone and Tissue Tracking Module which complies with The Joint Commission regulations for managing chain of custody for grafts and implants.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs